Background: Fractional microneedle radiofrequency (FMR) devices deliver energy to the deep dermis through insulated microneedles without destroying the epidermis. These FMR devices have been shown to be effective for the treatment of wrinkles, acne scars and large pores. In this study it was postulated that FMR energy could specifically affect the sweat glands, preserving the skin surface even if sweat glands were seated in the deep dermis. Objective: To evaluate the efficacy and safety of FMR for primary axillary hyperhidrosis (PAH) treatment and to conduct a histological analysis before and after treatment. Methods: Twenty patients with PAH had 2 sessions of bipolar FMR treatment at 4-week intervals. Clinical improvement was evaluated using a Hyperhidrosis Disease Severity Scale (HDSS) and photographs were taken using the starch-iodine test at every visit and 2 months after the last treatment. The amount of sweat reduction was indirectly assessed using a Tewameter™. Skin biopsies were obtained from 3 of the enrolled patients before and after treatment. The satisfaction and adverse reactions of the research participants were recorded at every follow-up visit. Results: HDSS scores decreased significantly from a baseline of 3.3 to 1.5 and 1.8 after the first and second months of posttreatment follow-up sessions, respectively (p < 0.001). In response to a subjective assessment at 1 month after the second treatment, 75% of patients (n = 15) had an HDSS score of 1 or 2, and 70% of patients (n = 14) expressed more than 50% improvement in their sweating. The starch-iodine reaction was also remarkably reduced in 95% of patients (n = 19) after FMR treatment. Histological findings showed a decrease in the number and size of both apocrine and eccrine glands 1 month after the final treatment. Side effects were minimal and included mild discomfort, transient swelling and postinflammatory hyperpigmentation. Conclusion: FMR treatment was effective for the treatment of PAH without significant adverse reactions due to direct volumetric heating of the lower dermis.

Atkins JL, Butler PE: Hyperhidrosis: a review of current management. Plast Reconstr Surg 2002;110:222-228.
Stolman LP: Treatment of excess sweating of the palms by iontophoresis. Arch Dermatol 1987;123:893-896.
Bechara FG, Georgas D, Sand M, Stücker M, Othlinghaus N, Altmeyer P, Gambichler T: Effects of a long-pulsed 800-nm diode laser on axillary hyperhidrosis: a randomized controlled half-side comparison study. Dermatol Surg 2012;38:736-740.
Goldman A, Wollina U: Subdermal Nd-YAG laser for axillary hyperhidrosis. Dermatol Surg 2008;34:756-762.
Kotlus BS: Treatment of refractory axillary hyperhidrosis with a 1,320-nm Nd:YAG laser. J Cosmet Laser Ther 2011;13:193-195.
Bechara FG, Altmeyer P, Sand M, Hoffmann K: Surgical treatment of axillary hyperhidrosis. Br J Dermatol 2007;156:398-399.
Unal O, Citgez B, Battal M, Karatepe O: Single incision thoracoscopic sympathectomy for hyperhidrosis. BMJ Case Rep 2012;2012.
Bechara FG, Sand M, Tomi NS, Altmeyer P, Hoffmann K: Repeat liposuction-curettage treatment of axillary hyperhidrosis is safe and effective. Br J Dermatol 2007;157:739-743.
Hoorens I, Ongenae K: Primary focal hyperhidrosis: current treatment options and a step-by-step approach. J Eur Acad Dermatol Venereol 2012;26:1-8.
Bushara KO, Park DM, Jones JC, Schutta HS: Botulinum toxin: a possible new treatment for axillary hyperhidrosis. Clin Exp Dermatol 1996;21:276-278.
Doft MA, Hardy KL, Ascherman JA: Treatment of hyperhidrosis with botulinum toxin. Aesthet Surg J 2012;32:238-244.
Hong HC, Lupin M, O'Shaughnessy KF: Clinical evaluation of a microwave device for treating axillary hyperhidrosis. Dermatol Surg 2012;38:728-735.
Alster TS, Lupton JR: Nonablative cutaneous remodeling using radiofrequency devices. Clin Dermatol 2007;25:487-491.
Elsaie ML, Choudhary S, Leiva A, Nouri K: Nonablative radiofrequency for skin rejuvenation. Dermatol Surg 2010;36:577-589.
Lolis MS, Goldberg DJ: Radiofrequency in cosmetic dermatology: a review. Dermatol Surg 2012;38:1765-1776.
Cho SI, Chung BY, Choi MG, Baek JH, Cho HJ, Park CW, Lee CH, Kim HO: Evaluation of the clinical efficacy of fractional radiofrequency microneedle treatment in acne scars and large facial pores. Dermatol Surg 2012; 38:1017-1024.
van Houte M, Harmsze AM, Deneer VH, Tupker RA: Effect of oxybutynin on exercise-induced sweating in healthy individuals. J Dermatolog Treat 2008;19:101-104.
Pinnagoda J, Tupker RA, Coenraads PJ, Nater JP: Transepidermal water loss with and without sweat gland inactivation. Contact Dermatitis 1989;21:16-22.
Goh CL: Aluminum chloride hexahydrate versus palmar hyperhidrosis: evaporimeter assessment. Int J Dermatol 1990;29:368-370.
Kobayashi T: Electrosurgery using insulated needles: epilation. J Dermatol Surg Oncol 1985;11:993-1000.
Kobayashi T: Electrosurgery using insulated needles: treatment of axillary bromhidrosis and hyperhidrosis. J Dermatol Surg Oncol 1988;14:749-752.
Solish N, Benohanian A, Kowalski JW, Canadian Dermatology Study Group on Health-Related Quality of Life in Primary Axillary Hyperhidrosis: Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life. Dermatol Surg 2005;31:405-413.
Hantash BM, Renton B, Berkowitz RL, Stridde BC, Newman J: Pilot clinical study of a novel minimally invasive bipolar microneedle radiofrequency device. Lasers Surg Med 2009;41:87-95.
Lawrence CM, Lonsdale Eccles AA: Selective sweat gland removal with minimal skin excision in the treatment of axillary hyperhidrosis: a retrospective clinical and histological review of 15 patients. Br J Dermatol 2006;155:115-118.
Grice K, Sattar H, Baker H: The effect of ambient humidity on transepidermal water loss. J Invest Dermatol 1972;58:343-346.
Hederman WP: Endoscopic sympathectomy. Br J Surg 1993;80:687-688.
Sung SW, Kim YT, Kim JH: Ultra-thin needle thoracoscopic surgery for hyperhidrosis with excellent cosmetic effects. Eur J Cardiothorac Surg 2000;17:691-696.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.